Introducing Falcon MLR, Veeva's AI-powered review platform, Hyland described a future in which AI acts less like a piece of ...
Donald Trump nominated Overton – a White House aide, physician, and vocal opponent of abortion – in the summer. The following ...
MSD has called a halt to three trials of BTK inhibitor nemtabrutinib – added to its pipeline through its $2.7 billion ...
The UK government has said it will end the NHS's controversial contract with US tech firm Palantir, but not until 2029 – two ...
Real-World Evidence for the Impact of Company-Led Medical Education – Medscape Medical Affairs explores the question of ...
Novo has published the results of a clinical trial of its Wegovy injection in children aged six to 12 with obesity, showing ...
AstraZeneca's rare disease unit Alexion has won regulatory approval in the US and EU for Klygefa as a generalised myasthenia ...
Nanoscope Therapeutics is on the brink of filing for FDA approval of what could be the first gene therapy for incurable eye disease retinitis pigmentosa (RP) that can be used regardless of underlying ...
Helus Pharma has revealed data from a phase 3 trial of HLP003 that showed evidence of efficacy in major depressive disorder ...
The FDA has said it cannot approve Summit Therapeutics and Akeso's PD-1xVEGF inhibitor ivonescimab, delaying a drug that is ...
New Orleans hosted this year’s AAPS PharmSci 360 at the Ernest N. Morial Convention Center. For those fortunate enough to ...
Asundexian has been approved by the FDA under the Sunharbo brand name for use in combination with antiplatelet therapy to ...